Factors affecting ability of TB patients to follow treatment guidelines - applying a capability approach.
Anti-tuberculosis treatment
Equity
Gender
National TB Elimination Programme
Socioeconomic deprivation
Journal
International journal for equity in health
ISSN: 1475-9276
Titre abrégé: Int J Equity Health
Pays: England
ID NLM: 101147692
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
received:
04
04
2023
accepted:
15
08
2023
medline:
5
9
2023
pubmed:
2
9
2023
entrez:
1
9
2023
Statut:
epublish
Résumé
Negotiating anti-Tuberculosis treatment is a complicated process comprising daily consumption of multiple medications at stipulated times and dosages, as well as periodic follow-ups and investigations, may not be uniform for all Tuberculosis (TB) patients and some may perform better than others. In this context, we conducted a study in Thiruvananthapuram district, Kerala to ascertain the ability of those suffering from TB to follow treatment guidelines. This study used an embedded mixed methods design. We collected cross-sectional data from 135 drug sensitive pulmonary TB patients aged 18 years or above in Thiruvananthapuram, Kerala using a structured questionnaire to get the proportion of patients following all treatment guidelines. We also did eight in-depth interviews (four men and four women) from within the survey sample. The in-depth interviews were inductively analysed for getting deeper insights about reasons for the choices people made regarding the treatment guidelines. Written informed consent was taken from all participants and the study was implemented after the necessary programmatic and ethical clearances. Of the 105 men and 30 women studied, uninterrupted daily drug consumption was reported by 80 persons (59.3%, 95% Confidence Intervals (CI) 50.8-67.2%). Overall, 38 (28.2%, 95% CI 21.3%-36.3%) persons were able to follow all seven aspects of advised guidelines. Living in an extended/ joint family (Adjusted Odds ratio (AOR) 2.6, 95% CI 1.1-6.0), approximate monthly household expenditure of over rupees 13,500 (AOR 2.9, 95% CI 1.3-6.7) and no perceived delay in seeking initial care (AOR 3.2, 95% CI 1.2-8.7) were significantly associated with following all aspects of treatment guidelines. In-depth interviews revealed reflective treatment related behaviours were influenced by bodily experiences, moral perceptions, social construct of TB, programmatic factors and substance use. Sometimes behaviours were non-reflective also. Programmatic stress was on individual agency for changing behaviour but capability and opportunity for these were influenced social aspects like stigma, gender roles and poverty. TB patients live amidst a syndemic of biomedical and social problems. These problems influence the capabilities and opportunities of such TB patients to follow treatment guidelines. Interventions should balance focus on individual agency and social abd economic factors.
Sections du résumé
BACKGROUND
Negotiating anti-Tuberculosis treatment is a complicated process comprising daily consumption of multiple medications at stipulated times and dosages, as well as periodic follow-ups and investigations, may not be uniform for all Tuberculosis (TB) patients and some may perform better than others. In this context, we conducted a study in Thiruvananthapuram district, Kerala to ascertain the ability of those suffering from TB to follow treatment guidelines.
METHODS
This study used an embedded mixed methods design. We collected cross-sectional data from 135 drug sensitive pulmonary TB patients aged 18 years or above in Thiruvananthapuram, Kerala using a structured questionnaire to get the proportion of patients following all treatment guidelines. We also did eight in-depth interviews (four men and four women) from within the survey sample. The in-depth interviews were inductively analysed for getting deeper insights about reasons for the choices people made regarding the treatment guidelines. Written informed consent was taken from all participants and the study was implemented after the necessary programmatic and ethical clearances.
RESULTS
Of the 105 men and 30 women studied, uninterrupted daily drug consumption was reported by 80 persons (59.3%, 95% Confidence Intervals (CI) 50.8-67.2%). Overall, 38 (28.2%, 95% CI 21.3%-36.3%) persons were able to follow all seven aspects of advised guidelines. Living in an extended/ joint family (Adjusted Odds ratio (AOR) 2.6, 95% CI 1.1-6.0), approximate monthly household expenditure of over rupees 13,500 (AOR 2.9, 95% CI 1.3-6.7) and no perceived delay in seeking initial care (AOR 3.2, 95% CI 1.2-8.7) were significantly associated with following all aspects of treatment guidelines. In-depth interviews revealed reflective treatment related behaviours were influenced by bodily experiences, moral perceptions, social construct of TB, programmatic factors and substance use. Sometimes behaviours were non-reflective also. Programmatic stress was on individual agency for changing behaviour but capability and opportunity for these were influenced social aspects like stigma, gender roles and poverty.
CONCLUSION
TB patients live amidst a syndemic of biomedical and social problems. These problems influence the capabilities and opportunities of such TB patients to follow treatment guidelines. Interventions should balance focus on individual agency and social abd economic factors.
Identifiants
pubmed: 37658369
doi: 10.1186/s12939-023-01991-7
pii: 10.1186/s12939-023-01991-7
pmc: PMC10474720
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
176Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
PLoS One. 2012;7(10):e46502
pubmed: 23077512
BMC Public Health. 2007 Aug 16;7:211
pubmed: 17705841
Int J Environ Res Public Health. 2020 Jun 30;17(13):
pubmed: 32629920
J Couns Psychol. 2017 Oct;64(5):500-513
pubmed: 29048196
J Biosoc Sci. 2019 May;51(3):403-417
pubmed: 30296952
Indian J Tuberc. 2015 Oct;62(4):230-4
pubmed: 26970465
Public Health Action. 2023 Mar 21;13(Suppl 1):44-50
pubmed: 36949740
F1000Res. 2022 Mar 1;11:253
pubmed: 36936050
Public Health. 2011 Feb;125(2):84-9
pubmed: 21288542
BMC Public Health. 2022 Sep 10;22(1):1717
pubmed: 36085073
Nat Hum Behav. 2022 Jan;6(1):64-73
pubmed: 34949783
Public Health. 2009 Jan;123(1):e14-20
pubmed: 19100588
Soc Sci Med. 1994 Mar;38(5):649-63
pubmed: 8171344
Scand J Public Health. 1999 Dec;27(4):290-5
pubmed: 10724473
Am J Public Health. 2010 Jan;100(1):41-9
pubmed: 19965570
Soc Sci Med. 2005 Oct;61(8):1701-10
pubmed: 15967558
Lancet. 2017 Mar 4;389(10072):964-977
pubmed: 28271847
Soc Sci Med. 1997 Feb;44(3):347-58
pubmed: 9004369
Open Forum Infect Dis. 2021 May 05;8(6):ofab190
pubmed: 34250181
BMC Public Health. 2021 Nov 11;21(1):2065
pubmed: 34763696
Indian J Tuberc. 2021 Jul;68(3):356-362
pubmed: 34099201